As of Apr 21
| -0.30 / -0.53%|
The 3 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 75.00, with a high estimate of 79.00 and a low estimate of 60.00. The median estimate represents a +32.74% increase from the last price of 56.50.
The current consensus among 3 polled investment analysts is to Buy stock in USANA Health Sciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.